Last quarter (Q ), Lucira Health's total revenue was $34.39M, an increase of 129.63% from the same quarter last year. In Q, Lucira Health's net income was $-126.86M. See Lucira Health’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 212.13M	$ 93.06M	$ 269.00K	$ 0.00	$ 0.00
Cost of Revenue	$ 251.16M	$ 82.83M	$ 1.94M	$ 0.00	-
Gross Profit	$ -39.02M	$ 10.22M	$ -1.67M	$ 0.00	-
Operating Expense	$ 102.65M	$ 74.76M	$ 28.11M	$ 7.70M	$ 6.16M
Operating Income	$ -141.67M	$ -64.54M	$ -29.78M	$ -7.70M	$ -6.16M
Net Non Operating Interest Income Expense	$ -1.57M	$ 11.00K	$ -53.00K	$ -90.00K	$ -190.00K
Other Income Expense	-	$ -281.00K	$ -7.51M	$ -674.00K	$ -183.00K
Pretax Income	$ -143.24M	$ -64.81M	$ -37.35M	$ -8.47M	$ -6.54M
Tax Provision	$ 16.00K	$ 17.00K	$ 0.00	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -143.28M	$ -64.83M	$ -37.35M	$ -8.47M	$ -6.54M
Basic EPS	$ -3.56	$ -1.86	$ -1.04	$ -1.07	$ -0.83
Diluted EPS	$ -3.58	$ -1.86	$ -1.04	$ -1.07	$ -0.83
Basic Average Shares	$ 158.91M	$ 34.77M	$ 35.87M	$ 7.91M	$ 7.91M
Diluted Average Shares	$ 161.01M	$ 34.77M	$ 35.87M	$ 7.91M	$ 7.91M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 353.81M	$ 157.59M	$ 30.05M	$ 7.70M	$ 6.16M
Net Income From Continuing And Discontinued Operation	$ -143.28M	$ -64.83M	$ -37.35M	$ -8.47M	$ -6.54M
Normalized Income	$ -143.28M	$ -64.62M	$ -29.83M	$ -7.79M	$ -6.35M
Interest Expense	$ 2.31M	$ 3.00K	$ 53.00K	$ 90.00K	$ 190.00K
EBIT	$ -141.20M	$ -64.81M	$ -37.30M	$ -8.38M	$ -6.35M
EBITDA	$ -134.68M	$ -61.14M	$ -37.02M	$ -8.09M	$ -6.10M

Currency in USD

Lucira Health Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing